Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 06 - 17 entities : Eli lilly and company save search
Innovent Announces First Patient Dosed in the Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion
Published: 2021-06-17 (Crawled : 01:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.22%
H: 1.28%
C: 0.88%
solid tumors trial
First Patient Dosed in Phase II Basket Trial of Taletrectinib for Solid Tumors with NTRK Fusion
Published: 2021-06-17 (Crawled : 01:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.22%
H: 1.28%
C: 0.88%
solid tumors trial
Insights on the Mantle Cell Lymphoma Treatment Global Market to 2029 - Key Drivers, Challenges and Opportunities
Published: 2021-06-17 (Crawled : 22:00) - prnewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -1.48%
H: 0.4%
C: -0.33%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.8%
H: 0.28%
C: -0.85%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.55%
H: 0.5%
C: 0.11%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.33%
H: 0.27%
C: -0.58%
treatment
$10+ Billion Blood Glucose Monitoring Devices Global Market to 2026 - Increasing Awareness About Point of Care Testing Presents Opportunities
Published: 2021-06-17 (Crawled : 21:00) - prnewswire.com
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: -1.29%
H: 0.62%
C: -0.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.18%
H: 0.56%
C: -0.79%
FMC A | $58.4 -0.43% 0.0% 1M
|
Process Industries
|
| O: -1.33%
H: 0.4%
C: -3.77%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.8%
H: 0.28%
C: -0.85%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -1.46%
H: 1.23%
C: 0.3%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.9%
H: 1.38%
C: 1.21%
DXCM | $137.86 2.88% 2.8% 3.2M
|
Health Technology
|
| O: -0.13%
H: 1.77%
C: 1.55%
blood test device
Lilly Launches Think Talk Treat Migraine™ to Help Improve Diagnosis and Treatment of Migraine
Published: 2021-06-17 (Crawled : 16:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.22%
H: 1.28%
C: 0.88%
treatment migraine diagnostic
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.